Glenmark Pharma

{
  "main_header": {
    "sid": 780863,
    "name": "Glenmark Pharma",
    "stock_name": "Glenmark Pharma",
    "full_name": "Glenmark Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/glenmark-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,452.85",
    "chg": 12.85,
    "chgp": "0.53%",
    "dir": 1,
    "prev_price": "2,440.00",
    "mcapval": "69,225.48 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532296,
    "symbol": "GLENMARK",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE935A01035",
    "curr_date": "Aug 27, 12:36 PM",
    "curr_time": "12:37 PM",
    "last_traded_at": "Aug 27, 12:36 PM IST",
    "bse_nse_vol": "3.08 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 27, 2026",
    "traded_date_str": "2026 08 27",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/glenmark-pharma-780863-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "SM",
      "url": "https://www.marketsmojo.com/mojopro/stock-of-the-month",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/glenmark-pharma-780863-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Glenmark Pharmaceuticals Ltd. to 52-Week High of Rs 2483.3",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-ltd-hits-new-52-week-high-at-rs24833-4171180",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GlenmarkPharmac_priceRelatedfactors_4171180.png",
        "date": "2026-08-27 09:46:27",
        "description": "With a decisive break above Rs 2483.3 on 27 Aug 2026, Glenmark Pharmaceuticals Ltd. has reached a fresh 52-week and all-time high, propelled by a confluence of strong technical indicators and sustained price momentum despite a broadly subdued market backdrop."
      },
      {
        "title": "Strong Momentum Meets Stretched Valuations as Glenmark Pharmaceuticals Ltd. Reaches All-Time High",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-ltd-stock-hits-all-time-high-at-rs-248330-4171124",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GlenmarkPharmac_priceRelatedfactors_4171124.png",
        "date": "2026-08-27 09:34:12",
        "description": ""
      },
      {
        "title": "Glenmark Pharmaceuticals Upgraded to Buy on Strong Technicals and Valuation Appeal",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/glenmark-pharmaceuticals-upgraded-to-buy-on-strong-technicals-and-valuation-appeal-4171018",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GlenmarkPharmac_mojoScore_4171018.png",
        "date": "2026-08-27 08:22:25",
        "description": "Glenmark Pharmaceuticals Ltd. has seen its investment rating upgraded from Hold to Buy, reflecting improved technical indicators, attractive valuation, solid financial trends, and enhanced quality metrics. The mid-cap pharmaceutical company’s recent performance and market positioning have prompted analysts to revise their outlook, signalling renewed investor confidence amid a challenging sector backdrop."
      },
      {
        "title": "Glenmark Pharmaceuticals Ltd. Technical Momentum Shifts to Bullish Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-ltd-technical-momentum-shifts-to-bullish-amid-strong-returns-4170871",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GlenmarkPharmac_technicaldot_4170871.png",
        "date": "2026-08-27 08:03:05",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by robust price action, positive signals from key technical indicators such as MACD and moving averages, and a strong performance relative to the broader market, signalling renewed investor interest in the mid-cap pharmaceutical player."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Sharp Open Interest Surge Amid Bullish Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-sharp-open-interest-surge-amid-bullish-market-signals-4167159",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GlenmarkPharmac_oi_spurts_by_underlying_4167159.png",
        "date": "2026-08-24 15:00:24",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and potential directional bets. The stock outperformed its sector peers today, supported by robust volume and a near 52-week high price, reflecting renewed investor confidence amid evolving market dynamics."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Significant Open Interest Surge Amid Bullish Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-significant-open-interest-surge-amid-bullish-market-signals-4167086",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GlenmarkPharmac_oi_spurts_by_underlying_4167086.png",
        "date": "2026-08-24 14:00:23",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent outperformance against its sector and the broader Sensex, combined with rising volumes and a strong technical setup, suggests evolving investor sentiment in the mid-cap pharmaceutical player."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Sharp Open Interest Surge Amid Bullish Derivatives Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-sharp-open-interest-surge-amid-bullish-derivatives-activity-4167049",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GlenmarkPharmac_oi_spurts_by_underlying_4167049.png",
        "date": "2026-08-24 13:00:18",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling a potential shift in market sentiment. The stock outperformed its sector peers and broader indices, supported by robust volume and rising futures activity, suggesting increased bullish positioning among traders."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Significant Open Interest Surge Amid Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-significant-open-interest-surge-amid-bullish-market-positioning-4166978",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GlenmarkPharmac_oi_spurts_by_underlying_4166978.png",
        "date": "2026-08-24 12:00:12",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a notable 13.3% increase in open interest in its derivatives segment, signalling a shift in market sentiment and positioning. This surge, coupled with rising volumes and price outperformance, suggests investors are recalibrating their directional bets on the mid-cap pharmaceutical player amid a mixed sector backdrop."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Significant Open Interest Surge Amidst Bullish Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-significant-open-interest-surge-amidst-bullish-market-signals-4166933",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GlenmarkPharmac_oi_spurts_by_underlying_4166933.png",
        "date": "2026-08-24 11:00:06",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a notable surge in open interest in its derivatives segment, signalling a shift in market sentiment and positioning. The stock outperformed its sector peers with a 2.09% gain, supported by increased futures and options activity, suggesting investors are taking fresh directional bets amid a backdrop of narrowing price ranges and strong technical momentum."
      }
    ],
    "total": 612,
    "sid": "780863",
    "stock_news_url": "https://www.marketsmojo.com/news/glenmark-pharmaceuticals-780863"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "21-Aug-2026",
      "details": "Glenmark Pharmaceuticals Inc. USA launches Calcium Gluconate Injection USP 1000 mg/10 mL (100 mg/mL) 5000 mg/50 mL (100 mg/mL) Single-Dose Vials and 10000 mg/100 mL (100 mg/mL) Pharmacy Bulk Package",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "20-Aug-2026",
      "details": "Glenmark Pharmaceuticals receives U.S. FDA approval for Fluticasone Propionate Nasal Spray 0.05 mg (50 mcg)/spray",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Aug-2026",
      "details": "Newspaper Advertisement regarding the 48th Annual General Meeting (\"AGM\") to be held on Friday September 11 2026 at 2.00 p.m. through Video Conferencing (\"VC\") / Other Audio-Visual Means (\"OAVM\")",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Glenmark Pharmaceuticals Ltd. has declared <strong>250%</strong> dividend, ex-date: 31 Aug 26",
          "dt": "2026-08-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Glenmark Pharmaceuticals Ltd. has announced <strong>1:2</strong> stock split, ex-date: 10 Sep 07",
          "dt": "2007-09-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Glenmark Pharmaceuticals Ltd. to 52-Week High of Rs 2483.3

2026-08-27 09:46:27

With a decisive break above Rs 2483.3 on 27 Aug 2026, Glenmark Pharmaceuticals Ltd. has reached a fresh 52-week and all-time high, propelled by a confluence of strong technical indicators and sustained price momentum despite a broadly subdued market backdrop.

Read full news article

Strong Momentum Meets Stretched Valuations as Glenmark Pharmaceuticals Ltd. Reaches All-Time High

2026-08-27 09:34:12

Read full news article

Glenmark Pharmaceuticals Upgraded to Buy on Strong Technicals and Valuation Appeal

2026-08-27 08:22:25

Glenmark Pharmaceuticals Ltd. has seen its investment rating upgraded from Hold to Buy, reflecting improved technical indicators, attractive valuation, solid financial trends, and enhanced quality metrics. The mid-cap pharmaceutical company’s recent performance and market positioning have prompted analysts to revise their outlook, signalling renewed investor confidence amid a challenging sector backdrop.

Read full news article

Glenmark Pharmaceuticals Ltd. Technical Momentum Shifts to Bullish Amid Strong Returns

2026-08-27 08:03:05

Glenmark Pharmaceuticals Ltd. has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by robust price action, positive signals from key technical indicators such as MACD and moving averages, and a strong performance relative to the broader market, signalling renewed investor interest in the mid-cap pharmaceutical player.

Read full news article

Glenmark Pharmaceuticals Sees Sharp Open Interest Surge Amid Bullish Market Signals

2026-08-24 15:00:24

Glenmark Pharmaceuticals Ltd. has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and potential directional bets. The stock outperformed its sector peers today, supported by robust volume and a near 52-week high price, reflecting renewed investor confidence amid evolving market dynamics.

Read full news article

Glenmark Pharmaceuticals Sees Significant Open Interest Surge Amid Bullish Market Signals

2026-08-24 14:00:23

Glenmark Pharmaceuticals Ltd. has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent outperformance against its sector and the broader Sensex, combined with rising volumes and a strong technical setup, suggests evolving investor sentiment in the mid-cap pharmaceutical player.

Read full news article

Glenmark Pharmaceuticals Sees Sharp Open Interest Surge Amid Bullish Derivatives Activity

2026-08-24 13:00:18

Glenmark Pharmaceuticals Ltd. has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling a potential shift in market sentiment. The stock outperformed its sector peers and broader indices, supported by robust volume and rising futures activity, suggesting increased bullish positioning among traders.

Read full news article

Glenmark Pharmaceuticals Sees Significant Open Interest Surge Amid Bullish Market Positioning

2026-08-24 12:00:12

Glenmark Pharmaceuticals Ltd. has witnessed a notable 13.3% increase in open interest in its derivatives segment, signalling a shift in market sentiment and positioning. This surge, coupled with rising volumes and price outperformance, suggests investors are recalibrating their directional bets on the mid-cap pharmaceutical player amid a mixed sector backdrop.

Read full news article

Glenmark Pharmaceuticals Sees Significant Open Interest Surge Amidst Bullish Market Signals

2026-08-24 11:00:06

Glenmark Pharmaceuticals Ltd. has witnessed a notable surge in open interest in its derivatives segment, signalling a shift in market sentiment and positioning. The stock outperformed its sector peers with a 2.09% gain, supported by increased futures and options activity, suggesting investors are taking fresh directional bets amid a backdrop of narrowing price ranges and strong technical momentum.

Read full news article

View All News